Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
It is generally accepted that the phospholipase‐A 2‐cyclooxygenase‐prostanoids‐cascade mediates spinal sensitization and hyperalgesia. However, some observations are not in line with this hypothesis. The aim of the present work was to investigate whether different components of this cascade exhibit nociceptive or antinociceptive effects in the rat formalin test. Intrathecal (i.th.) injection of prostaglandin E 2 (PGE 2) induced a dose‐dependent antinociceptive effect on the formalin‐induced nociception. Furthermore, thimerosal, which inhibits the reacylation of arachidonic acid thereby enhancing arachidonic acid levels, had an antinociceptive effect rather than the expected pronociceptive effect when given i.th. While the phospholipase A 2 inhibitor methyl arachidonyl fluorophosphonate (MAFP; i.th.) had a significant antinociceptive effect, its analogue palmitoyl trifluoromethyl ketone (PTFMK; i.th.) had no significant effect on the formalin‐induced nociception. However, MAFP, but not PTFMK, showed a cannabinoid CB 1 agonistic effect as shown by the inhibition of electrically evoked contractions of the vas deferens isolated from CB 1 wild‐type mice but not of that from CB 1 knockout mice. The antinociceptive effect of MAFP was completely reversed by the CB 1 receptor antagonist AM‐251 (i.th.), thus attributing such effect to its CB 1 agonistic effect. Moreover, the antinociceptive effect of the cyclooxygenase inhibitor, flurbiprofen (i.th.) was reversed by the co‐administration of AM‐251, but not by PGE 2. Finally. the combination of phenylmethylsulfonyl fluoride (PMSF; intraperitoneal), which inhibits the degradation of anandamide through the inhibition of fatty acid amidohydrolase, with thimerosal (i.th.) produced a profound CB 1‐dependent antinociception. The present results show that endocannabinoids play a major role in mediating flurbiprofen‐induced antinociception at the spinal level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ethical guidelines for investigations of experimental pain in conscious animals.
Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762 · cited 1×
“The ethical guidelines for investigations of experimental pain in conscious animals (Zimmermann, 1983) were followed and the local ethical committee approved experiments.”
BackgroundMechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“In this regard one should consider, that endocannabinoids show antinociceptive effects in several pain models (e.g. Mechoulam et al., 1995; Pertwee, 2001).”
BackgroundInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Gatley, S. J., Gifford, A. N., Volkow, N. D., Lan, R., & Makriyannis, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00279-8 · Cited by 252 · cited 2×
“It is known that CB1 receptors represent the predominate isoform within the central nervous system (for review see Howlett et al., 2002), therefore our study was carried out using AM-251, which is a more selective CB1 antagonist than the prototype SR141716A (Gatley et al., 1996).”
BackgroundMethod
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
The Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
Farooqui, A. A., Ong, W.-Y., & Horrocks, L. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.7 · Cited by 368
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Lambert, D. M., & Fowler, C. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058183t · Cited by 350
Metadata
- Authors
- Ates, M., Hamza, M., Seidel, K., Kotalla, C. E., Ledent, C., & Gühring, H.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2003-01-31
- Volume
- 17
- Issue
- 3
- Pages
- 597-604
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1964840757
- Cited by
- 78
- References
- 5
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test. https://app.cochat.ai/papers/10.1046/j.1460-9568.2003.02470.x
- The paper
- Ates, M., Hamza, M., Seidel, K., Kotalla, C. E., Ledent, C., & Gühring, H. (2003). Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test. European Journal of Neuroscience. https://doi.org/10.1046/j.1460-9568.2003.02470.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.